BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7579492)

  • 1. Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients.
    Jäger W; Sauerbrei W
    Breast Cancer Res Treat; 1995 Jun; 34(3):279-87. PubMed ID: 7579492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal women.
    Milella M; Nisticò C; Ferraresi V; Vaccaro A; Fabi A; D'Ottavio AM; Botti C; Giannarelli D; Lopez M; Cortesi E; Foggi CM; Antimi M; Terzoli E; Cognetti F; Papaldo P
    Breast Cancer Res Treat; 1999 Jun; 55(3):259-66. PubMed ID: 10517170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of surgery related to menstrual cycle and prognosis of premenopausal women with breast cancer.
    Mondini G; Decian F; Sorice G; Friedman D; Spirito C; Costantini M; Sormani MP; Civalleri D
    Anticancer Res; 1997; 17(1B):787-90. PubMed ID: 9066621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal patients with early breast cancer.
    Nomura Y; Kataoka A; Tsutsui S; Murakami S; Takenaka Y
    Eur J Cancer; 1999 Sep; 35(9):1326-30. PubMed ID: 10658522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the timing of surgery for breast cancer in relation to the menstrual cycle or geomagnetic activity affect prognoses of premenopausal patients?
    Takeda Y; Yanagie H; Yoshizaki I; Eriguchi M
    Biomed Pharmacother; 2003 Oct; 57 Suppl 1():96s-103s. PubMed ID: 14572684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI.
    Goldhirsch A; Gelber RD; Castiglione M; O'Neill A; Thürlimann B; Rudenstam CM; Lindtner J; Collins J; Forbes J; Crivellari D; Coates A; Cavalli F; Simoncini E; Fey MF; Pagani O; Price K; Senn HJ
    Ann Oncol; 1997 Aug; 8(8):751-6. PubMed ID: 9332682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.
    Pujol P; Daures JP; Brouillet JP; Chang S; Rouanet P; Bringer J; Grenier J; Maudelonde T
    Cancer; 2001 May; 91(10):1854-61. PubMed ID: 11346866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group.
    Colleoni M; Bonetti M; Coates AS; Castiglione-Gertsch M; Gelber RD; Price K; Rudenstam CM; Lindtner J; Collins J; Thürlimann B; Holmberg S; Veronesi A; Marini G; Goldhirsch A
    J Clin Oncol; 2000 Feb; 18(3):584-90. PubMed ID: 10653873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phase of the menstrual cycle has no influence on the disease-free survival of patients with mammary carcinoma.
    Wobbes T; Thomas CM; Segers MF; Peer PG; Bruggink ED; Beex LV
    Br J Cancer; 1994 Mar; 69(3):599-600. PubMed ID: 8123495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal breast cancer patients.
    Takeda Y; Nonaka Y; Yanagie H; Yoshizaki I; Eriguchi M
    Biomed Pharmacother; 2001; 55 Suppl 1():133s-137s. PubMed ID: 11774860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of adjuvant surgical oophorectomy in the menstrual cycle and disease-free and overall survival in premenopausal women with operable breast cancer.
    Love RR; Laudico AV; Van Dinh N; Allred DC; Uy GB; Quang le H; Salvador JD; Siguan SS; Mirasol-Lumague MR; Tung ND; Benjaafar N; Navarro NS; Quy TT; De La Peña AS; Dofitas RB; Bisquera OC; Linh ND; To TV; Young GS; Hade EM; Jarjoura D
    J Natl Cancer Inst; 2015 Jun; 107(6):djv064. PubMed ID: 25794890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of breast surgery in premenopausal breast cancer patients.
    Samuel M; Wai KL; Brennan VK; Yong WS
    Cochrane Database Syst Rev; 2011 May; 2011(5):CD003720. PubMed ID: 21563138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of surgery in relation to the menstrual cycle in premenopausal women with operable breast cancer.
    Saad Z; Bramwell V; Duff J; Girotti M; Jory T; Heathcote G; Turnbull I; Garcia B; Stitt L
    Br J Surg; 1994 Feb; 81(2):217-20. PubMed ID: 8156340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study.
    Grant CS; Ingle JN; Suman VJ; Dumesic DA; Wickerham DL; Gelber RD; Flynn PJ; Weir LM; Intra M; Jones WO; Perez EA; Hartmann LC
    J Clin Oncol; 2009 Aug; 27(22):3620-6. PubMed ID: 19487378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor.
    Cooper LS; Gillett CE; Patel NK; Barnes DM; Fentiman IS
    Cancer; 1999 Nov; 86(10):2053-8. PubMed ID: 10570431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.
    Clahsen PC; van de Velde CJ; Julien JP; Floiras JL; Delozier T; Mignolet FY; Sahmoud TM
    J Clin Oncol; 1996 Mar; 14(3):745-53. PubMed ID: 8622020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lacking effect of timing of surgery in relation to the menstrual cycle on prognosis of breast cancer in premenopausal women].
    Mondini G; Friedman D; De Cian F; Spirito C; Carrabetta S; Costantini M; Sormani MP; Civalleri D
    G Chir; 1997; 18(1-2):7-11. PubMed ID: 9206487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
    Dubsky P; Sevelda P; Jakesz R; Hausmaninger H; Samonigg H; Seifert M; Denison U; Mlineritsch B; Steger G; Kwasny W; Stöger H; Bartsch R; Stierer M; Taucher S; Fridrik M; Schippinger W; Greil R; Pötter R; Gnant M;
    Clin Cancer Res; 2008 Apr; 14(7):2082-7. PubMed ID: 18381948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of surgery in relation to the menstrual cycle and its influence on the survival of Japanese women with operable breast cancer.
    Kurebayashi J; Sonoo H; Shimozuma K
    Surg Today; 1995; 25(6):519-24. PubMed ID: 7579959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial.
    Andersson M; Kamby C; Jensen MB; Mouridsen H; Ejlertsen B; Dombernowsky P; Rose C; Cold S; Overgaard M; Andersen J; Kjaer M
    Eur J Cancer; 1999 Nov; 35(12):1659-66. PubMed ID: 10674010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.